Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Dose Ranging Study of Lutein Supplementation in Persons over age 60

Go back to Resources

Dose Ranging Study of Lutein Supplementation in Persons over age 60

Authors:

Location:

Go back to Resources

Do they stay or do they go: characterizing long-term study follow-up in the Age-Related Eye Disease Study

Go back to Resources

Do they stay or do they go: characterizing long-term study follow-up in the Age-Related Eye Disease Study

Authors:

Location:

Go back to Resources

Do antioxidants or zinc affect cognitive function in an older population?

Go back to Resources

Do antioxidants or zinc affect cognitive function in an older population?

Authors:

Location:

Go back to Resources

Dietary Omega-3 long-chain polyunsaturated fatty acids and risk for age-related macular degeneration

Go back to Resources

Dietary Omega-3 long-chain polyunsaturated fatty acids and risk for age-related macular degeneration

Authors:

Location:

Go back to Resources

Dietary intake studies, randomized trials of nutritional supplements, and resulting public impact

Go back to Resources

Dietary intake studies, randomized trials of nutritional supplements, and resulting public impact

Authors:

Location:

Go back to Resources

Dietary intake studies of antioxidants or zinc versus high-dose supplements in a randomized clinical trial; associations with cognitive impairment

Go back to Resources

Dietary intake studies of antioxidants or zinc versus high-dose supplements in a randomized clinical trial; associations with cognitive impairment

Authors:

Location:

Go back to Resources

Development of the National Eye Institute Refractive Error Correction Quality of Life Questionnaire (NEI-RQL) Part I: Focus Group

Go back to Resources

Development of the National Eye Institute Refractive Error Correction Quality of Life Questionnaire (NEI-RQL) Part I: Focus Group

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy

Go back to Resources

Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy

Authors:

Location:

Go back to Resources

Collaborative iIslet Transplant Registry

Go back to Resources

Collaborative iIslet Transplant Registry

Authors:

Secondary:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience

Go back to Resources

Busulfan/melphalan/ATG (Bu/Mel/ATG) as a preparative regimen for unrelated donor cord blood transplantation (UCBT): the COBLT experience

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • Current page 139
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions